Please login to the form below

Not currently logged in
Email:
Password:

Peter Kelly named managing director of Accord Healthcare UK

He was previously commercial director at Actavis UK

Peter Kelly Accord Healthcare ActavisAccord Healthcare has appointed Peter Kelly as its UK managing director, a move that sees him transition from Actavis, whose UK and Ireland operations Accord acquired last year.

Kelly spent 12 years at Actavis, most recently as commercial director. The Actavis Generics business was acquired from Allergan in 2016 by Teva, which then sold a chunk of it to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals.

Kelly said: “Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK, with us supplying one in six of the UK’s generic medicines. We remain committed to R&D and bringing cost competitive new products to market at the earliest opportunity.

“This is an exciting opportunity to lead our teams of brilliant people who continue to focus on excellent service, allowing us to work in partnership with customers as their Partner of Choice.”

Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord Healthcare.

He spent three years heading up Actavis’ UK operations and before that help senior commercial roles at Sandoz and Novartis.

11th July 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics